RAMAT GAN, Israel, Dec. 04, 2024 (GLOBE NEWSWIRE) -- (NYSE American: CANF) (TASE: CANF), a biotechnology company advancing a ...

Analysts called the data “very competitive” but raised questions about safety. Merck gained ownership of the ADC when it ...

The building is slated to be ready for occupancy in a month. The secured entrance offers a large receptionist area. A few ...

The Archbishop of Liverpool Malcolm McMahon formally recognised the cure of John Traynor during the archdiocese’s first ...

Antibiotic drugs are considered the first line of treatment for urinary tract infections (UTIs). Other medications and ...

Patients with locally advanced hepatocellular carcinoma (HCC) who achieve a complete response after locoregional therapy and ...

A subgroup analysis showed that epcoritamab is effective regardless of CAR T–exposure in patients with R/R LBCL.

good quality of life and is defined as a long term complete response. Namodenoson has Orphan Drug status with both the FDA and EMA, as well as Fast Track Status with the FDA for the treatment of ...

There may be an effective new treatment for people with bladder cancer that doesn't respond to a frontline therapy.

CF602, the Company's third drug candidate, has shown efficacy in the treatment of erectile dysfunction ... into clinical trials or to successfully complete our preclinical studies or clinical ...

Late-breaking research reveals there is no benefit from high-dose chemotherapy followed by autologous stem cell transplant ...